Key result
Nerol reduces ouabain-induced arrhythmia severity by ~85% in preclinical models, driven by ICa,L inhibition.
Why the study?
The contractile, electrophysiological, and antiarrhythmic properties of the monoterpene nerol in mammalian heart preparations required evaluation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for nerol in preclinical arrhythmia models; leaves open clinical translation and safety.
Nerol (C10H18O) is a monoterpene found in many essential oils, such as lemon balm and hop. In this study, we explored the contractile and electrophysiological properties of nerol and demonstrated its antiarrhythmic effects in guinea pig heart preparation. Nerol effects were evaluated on atrial and ventricular tissue contractility, electrocardiogram (ECG), voltage-dependent L-type Ca2+current (ICa,L), and ouabain-triggered arrhythmias. Overall our results revealed that by increasing concentrations of nerol (from 0.001 to 30 mM) there was a significant decrease in left atrium contractile force. This effect was completely and rapidly reversible after washing out (~ 2 min). Nerol (at 3 mM concentration) decreased the left atrium positive inotropic response evoked by adding up CaCl2in the extracellular medium. Interestingly, when using a lower concentration of nerol (30μM), it was not possible to clearly observe any significant ECG signal alterations but a small reduction of ventricular contractility was observed. In addition, 300μM nerol promoted a significant decrease on the cardiac rate and contractility. Important to note is the fact that in isolated cardiomyocytes, peak ICa,Lwas reduced by 58.9 ± 6.31% after perfusing 300μM nerol (n=7, p<0.05). Nerol, at 30 and 300μM, delayed the time of onset of ouabain-triggered arrhythmias and provoked a decrease in the diastolic tension induced by the presence of ouabain (50μM). Furthermore, nerol preincubation significantly attenuated arrhythmia severity index without changes in the positive inotropism elicited by ouabain exposure. Taken all together, we may be able to conclude that nerol primarily by reducing Ca2+influx through L-type Ca2+channel blockade lessened the severity of ouabain-triggered arrhythmias in mammalian heart.
No takes yet. Share an insight, caveat, or question.
Menezes‐Filho et al. (2019) studied Ouabain-induced cardiac arrhythmias. Nerol vs. Ouabain alone (50 μM) or nifedipine (0.35 μM) plus ouabain was evaluated on Arrhythmia severity score (arbitrary units, a.u.) during 50 μM ouabain exposure (p=<0.05). Nerol preincubation (30 and 300 μM) significantly reduced the ouabain-induced arrhythmia severity score from 43.6 to 6.6 and 12.2 a.u. (p<0.05) and inhibited peak ICa,L by 58.9% in guinea pig hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: